37
TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances Ministry of Health REPUBLIC OF MACEDONIA E-mail: [email protected] COMMUNITY AGENCIES PARTNERS IN ACCESSION 25-27 November 2009, Sintra, Portugal

TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Embed Size (px)

Citation preview

Page 1: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

TATJANA PETRUSEVSKA Spec. Pharm. MBAVice President of Inter Ministerial Commission for Narcotic Drugs (IMCND)Head of Sector for Controlled substancesMinistry of Health

REPUBLIC OF MACEDONIAE-mail: [email protected]

COMMUNITY AGENCIES

PARTNERS IN ACCESSION 25-27 November 2009, Sintra, Portugal

Page 2: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

LESSONS LEARNED

Experiences of the IMCND of the Republic of Macedonia and EU

Agency EMCDDA

Page 4: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Membership of the European Union is the highest strategic interest and priority for the Government of the Republic of Macedonia, an objective shared by an overwhelming majority of Macedonia’s citizens and all political parties. Macedonia was the first country in South East Europe to sign a Stabilization and Association Agreement with the European Union in 2001 in Luxemburg. Recognizing the progress that Macedonia has made in meeting the Copenhagen criteria, the European Commission recommended granting Macedonia candidate country status for membership in the EU. On 17 December 2005, the European Council decided to grant the Republic of Macedonia official candidate status for EU membership.

Page 5: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances
Page 6: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

MACEDONIAN EXPERIENCES WITH EU INSTRUMENTS:

2001 PHARE Project for synthetic drugs 2001 PHARE Project for precursor control

*Within this project we prepared Law for control of precursors in line with EU directives

2006-2007 CARDS Project for combating drugs related criminal activities:

*we prepared National Drug strategy, Action Plan, Law for control of narcotics and psychotropic substances

*NFP has been established 2008 CARDS Project with EMCDDA:ESPAD study. Need assessment report, Country overview, Info

Map,

Page 7: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

…..Where we were…..

Where we want to be, with support of our ....

Colleagues

Partners and Friends

Page 8: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

“United in diversity” is the motto of the European Union

Page 9: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

We learned…

…A diverse workforce provides talent, creativity, flexibility, world vision and strength, that we need to

successfully complete Global goals…

Page 10: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Finding yourself in Diversity!

Page 11: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

ppreciate

articipate

elebrate

We learned…

Page 12: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Appreciate:

religion

physical characteristics

race

gender

marriage status

family

ethnicity

language

Geographic origin

Socioeconomic status

Page 13: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

• What a Diversity Provides?– A variety of points of view and approaches to problems and

opportunities can improve managerial decision making.– Diverse can provide a wider range of creative ideas.– Needs of diverse stakeholders,– Factors that Influence Managerial Perception– Accommodation for Religious Beliefs– Scheduling of critical meetings,– Providing flexible time off for holy days– Perceptions,– Avoid stereotyping, – Recognize & celebrate differences,– Language translations

Managing Diversity Effectively Makes Good Sense

Page 14: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

PLANNING PROCESS

Organize the stakeholders to

profile the needs and readiness

Assessment

Mobilize the stakeholders & build capacity to address the

needs

Developed the plan (activities, programs and

strategies) Implementation of the plan

Evaluate the Results and estimation of

the Future support

CAPACITY

PLANNING

Implementation

Evaluation

SUSTAINABILITY

WE LEARNED:

SYNERGY enables the total performance to be greater

WE LEARNED:

Page 15: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Capacity building process1. Assess the 1. Assess the

resources and needsresources and needs

Page 16: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

2. Support services 2. Support services expansionexpansion

Improve service Improve service organization and financingorganization and financing

1. Assess the 1. Assess the resources and needsresources and needs

Capacity building process

Page 17: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

EFFECTIVNESS

IMPROVE QUALITYIMPROVE QUALITY

Evidence-based approachEvidence-based approach

TrainingsTrainings

EducationEducation

OUR VISION

Page 18: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Capacity building process

2. Support services 2. Support services expansionexpansion

3. Improve service 3. Improve service organization and financingorganization and financing

4. Recruit, educate and 4. Recruit, educate and retain workforceretain workforce

1. Assess the resources and 1. Assess the resources and needsneeds

5. Create interlocking 5. Create interlocking systems of caresystems of care

6. Development a 6. Development a standards to monitor the standards to monitor the

systemsystem

Page 19: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

EMCDDA–CARDS project• Objective 32 of the EU drugs action plan 2005–08

foresees that particular efforts must be made to improve assistance given to applicant countries.

On 1 December 2007, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) initiated a technical cooperation and assistance project with the Western Balkans countries — comprising Albania, Bosnia-Herzegovina, Republic of Macedonia, Montenegro, Serbia — financed by the European Commission’s (CARDS) fund.

• The aim of the project was to assess the capacity of the Western Balkans countries to establish a drug information system that is compatible with the EMCDDA, and to provide direct support for data collection and reporting.

• During this first cooperation project with the Western Balkans, the EMCDDA and the Reitox coaches assisted the partner countries in drafting a first Country overview following the European standards.

Page 20: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

WE LEARNED:

The central role of networking, multidisciplinary work and care coordination

The use of reliable and valid screening instruments for assessments

What information and/or data exists that is of relevance for

the implementation of the action?– International databases (scientific, legislation)– Epidemiology surveys on drug use (patterns, treatment, etc.)– Policy research (evaluation research, etc.)– Registries (e.g. clients in treatment)– Qualitative data e.g. rapid assessment information– Effectiveness/ implementation studies

Page 21: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Ideally Actions are: • Specific (focusing on a specific problem or issue)• Measurable (the progress and outcome must be measurable through objective

indicators and assessed with existing verification tools as much as possible)• Acceptable (the priority aims and actions must be in agreement with generally

supported principles and contexts in society and in the Strategy)• Realistic (the priority aims and actions can be ambitious, but should be feasible

within the given context, resources and timeframe of the Strategy)• Time bound (priority aims need to be reachable in 8 years time, actions in (at

maximum) 4 years time))Have: • Added value (priority aims and actions need to provide an added value to the

current situation)Respect:• Proportionality (The scope and consequences of priority aims and actions are

proportional compared to the problem they aim to address)Reflect: • Effectiveness & Efficiency (Priority aims and actions are expected to provide best

results at the most economic cost)• Knowledge base (Priority aims and actions are based upon evidence)

Action Plan Criteria

Page 22: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Annual planning process

Mid-term assessment of compliance with Strategy objectives

Prioritisation within department and with executive agencies

Feedback to IMCD & discussion priorities

IMCD focus: coherence & selection

IMCDAction plan Proposal Feedback on

compliance(monitoring)

Political decision-making

Stakeholder involvement, i.e. in expert committees

Implemen-tation by responsible department & agencies

Budgeting & planning by department & executive agencies

Monitoring & (external) Evaluation

Coordination

Feedback to IMCD & discussion

Next cycle

Coordination level

Implementation level

Stakeholder involvement

Stakeholder involvement``

Stakeholder involvement

WE LEARNED:

Page 23: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

A process by which an experienced member of an organization (the mentor) provides

advice and guidance to an less experienced member (the protégé) and helps the less

experienced member learn how …..

We learned about mentoring process…

Page 24: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Mr.Ernestas Jasaitis ,National Focal Point from Lithuania and Mr. Neoklis Georgiades, Cyprus NFP

And EMCDDA Team

Reitox coaches for the Macedonian National

Focal Point were

Page 25: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

We learned…

Establish standardsEstablish standards

Measure actual performanceMeasure actual performance

CompareCompare

Evaluate & take corrective actionEvaluate & take corrective action

1.

2.

3.

4.

Page 26: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Time

Effort

Education

Experience

Skills

Knowledge

Contributes to efficiency,

Effectiveness,

And the attainment of

the goals

Accomplishment satisfaction

IMPUTS

IMPUTS PERFORMANCE OUTCOMES

Page 27: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

• Objectively verifiable INDICATOR – Clear measurement that can be directly attributed to the

action.

• Example– Increase coverage and availability of effective

treatment for drug addiction– Indicator: Treatment Demand Indicator

Expected out come/impact

Page 28: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

• New approaches to maximize the analytical value of the available information;

• To combine different types of information (qualitative/quantitative) and levels of analysis (local/national, regional)

• Multi-methods approaches, sensitivity and timeliness, value in working together,

• Strong commitment to evidence-driven policies,• We appreciate EMCDDA to continue to monitor and

support research developments in Macedonia.

Cooperation with EMCDDA, opened new Horizons

Page 29: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

EMCDDA

National Focal Point

MINISTRY OF HEALTH, Sector for controlled substances

coordinate with

Institute for Public Health

Centers for treatment of drug abusers

Clinical Centers

MINISTRY OF INTERIOR

NGO sectorMINISTRY FOR EDUCATION AND

SCIENCE

Ministry for labor and social policy

Page 30: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances
Page 31: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances
Page 32: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Key challenges:To strengthen MKD NFP role as platform

for knowledge exchange,Making better use of expert networks,Developing best practice portal,Support the development of EMCDDA

guidelines based on national and international experiences,

Working in partnership with EMCDDA to set out programs, reporting structures & instruments and quality standards,

Provided added value at national level.

Page 33: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

Key challenges…Quality and standardization of data

collection and analysis,Quality assurance of information out puts,Development of National Information

System,Maintaining support and co-operation at

national level,Encouraging collection of standardized

data with recognising national needs and deferences

Information exchange within REITOX network,

Adapting to changing requirement with limited resources.

Page 34: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

To Increase common understanding of complex drug phenomenon…

Page 35: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances
Page 36: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

For the next IPA in cooperation with EMCDDA we will work on:

Awareness raising for the importance of collecting reliable and comparable information on the drug situation and on response to it,

The need of evidence based policies,

The importance of providing timely and relevant information to policy makers and professionals in the field,

The need to maintain high scientific standards and procedures,

To maintain balanced approached between policy and science.

Page 37: TATJANA PETRUSEVSKA Spec. Pharm. MBA Vice President of Inter Ministerial Commission for Narcotic Drugs (IMCND) Head of Sector for Controlled substances

THANK YOU